SU133422A1 - Medicinal product - rennet powder - Google Patents
Medicinal product - rennet powderInfo
- Publication number
- SU133422A1 SU133422A1 SU660682A SU660682A SU133422A1 SU 133422 A1 SU133422 A1 SU 133422A1 SU 660682 A SU660682 A SU 660682A SU 660682 A SU660682 A SU 660682A SU 133422 A1 SU133422 A1 SU 133422A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- rennet
- powder
- medicinal product
- rennet powder
- acute
- Prior art date
Links
Landscapes
- Dairy Products (AREA)
- Fodder In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
Сычужный Порошок: (сычужный фермент) вл етс препаратом протеолитических ферментов желудочно-кишечного тракта. Извлекаетс из сЫчугов тел т и гн т молочного возраста 10%-ным раствором поваренной соли и высаливаетс прн помоши сол ной кислоты; до насто ш .его времени имел .применение только в сыроделии, В производстве сыроз.Rennet Powder: (rennet) is a preparation of proteolytic enzymes of the gastrointestinal tract. It is extracted from syringes from calves and milked from milky age with a 10% solution of sodium chloride and salted out with hydrochloric acid; up to the present time, it had only application in cheese making, in the production of cheese.
Применение сычужного порошка в качестве лечебного препарата при желудочно-кишечных заболевани х до сих пор не было известно.The use of rennet powder as a therapeutic agent for gastrointestinal diseases has not yet been known.
Установлено, что сычужный порошок (фермент) вл етс высокоактивным препаратОМ при лечении хронических и, острых заболеваний желудочно-кишечного тракта: острый гастрит, острый гастроэнтерит, острый гастроэнтероколит, .при лечении острой и хронической дезинтерии (после отмены антибиотиков), при хропических гастритах, при хронических колитах, влени х дискензии, -при дуодените и т. п.Rennet powder (enzyme) has been found to be a highly active drug in the treatment of chronic and acute diseases of the gastrointestinal tract: acute gastritis, acute gastroenteritis, acute gastroenterocolitis, in the treatment of acute and chronic disintegration (after discontinuation of antibiotics), in tropical gastritis in chronic colitis, symptoms of dispensia, in duodenitis, etc.
Сычужный Порошок, предложенный в качестве лечебного препарата , примен етс по следуюш,ей методике. Таблетки сычужного порошка весом 0,2 г принимаютс во врем еды три раза .в день по одной таблетке в,течение 1-2 мес цев; при т желых заболевани х дозировка увеличиваетс до 3 таблеток на прием и курс лечени .продлеваетс до 3 мес цев; при острых заболевани х - по 1 таблетке 3 раза в день в течение 2-3 дней.Rennet Powder, proposed as a therapeutic drug, is applied according to the following procedure. Tablets of rennet powder weighing 0.2 g are taken during meals three times a day, one tablet per 1-2 months; with severe diseases, the dosage is increased to 3 tablets per dose and the course of treatment is extended up to 3 months; in case of acute diseases - 1 tablet 3 times a day for 2-3 days.
Препарат совершенно безвреден и невызывает никаких побочны.х влений.The drug is completely harmless and does not cause any side effects.
Применение -в медицинской практике препарата «сычужный порошок разрешено Формакологическим Комитетом Министерства здравоохранени СССР (протокол № 10 от 9 ма 1960 г.).Use in the medical practice of the drug “rennet powder is permitted by the Formological Committee of the USSR Ministry of Health (Minutes No. 10 dated May 9, 1960).
;Предмет изобретени ; Subject of the invention
Применение в медицинской практике «сычзжного порошка, вл ющегос Препаратом протеолитических ферментов желздочно-кишечлого тракта, дл лечени различных острых и хронических желудочно-кишечных заболеваний.Use in medical practice of "Syzhozhnogo powder, which is a preparation of proteolytic enzymes of the gastrointestinal tract, for the treatment of various acute and chronic gastrointestinal diseases.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU660682A SU133422A1 (en) | 1960-03-26 | 1960-03-26 | Medicinal product - rennet powder |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU660682A SU133422A1 (en) | 1960-03-26 | 1960-03-26 | Medicinal product - rennet powder |
Publications (1)
Publication Number | Publication Date |
---|---|
SU133422A1 true SU133422A1 (en) | 1960-11-30 |
Family
ID=48404421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU660682A SU133422A1 (en) | 1960-03-26 | 1960-03-26 | Medicinal product - rennet powder |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU133422A1 (en) |
-
1960
- 1960-03-26 SU SU660682A patent/SU133422A1/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO821832L (en) | PROCEDURE FOR THE PREPARATION OF ALLERGIC Capsules | |
Spies et al. | Pantothenic acid in human nutrition | |
BR112020000570A2 (en) | propionic and / or butyric acid for use in the prophylactic and / or supportive therapeutic treatment of morbus parkinson | |
SU133422A1 (en) | Medicinal product - rennet powder | |
JPS5938203B2 (en) | A therapeutic agent for cerebral circulation disorders whose main ingredient is coenzyme Q. | |
Altemeier et al. | Penicillin therapy in rat bite fever | |
FR2358893A1 (en) | ANTIMICROBIAL COMPOSITION CONTAINING 1-IMIDAZOLYL-BUTANE-2-ONES OR -BUTANE-2-OLS HALOGENES | |
Hyman | Anaphylactic shock after therapy with penicillinase | |
Miller et al. | Treatment of enterobiasis with dithiazanine | |
SCHAEFER et al. | Sodium gentisate in the treatment of acute rheumatic fever | |
ES2399269T3 (en) | Compositions comprising components coated with a liquid impermeable but gas permeable layer, use thereof for skin treatment and other diseases of the exocrine gland | |
SILVERMAN et al. | Toxic effects of diodoquin | |
SU263808A1 (en) | Medical preparation | |
Hendricks et al. | Spotted fever treated with para-aminobenzoic acid | |
GB950162A (en) | Medicines for the treatment of hepatic disorders | |
Bach et al. | Rheumatic fever | |
GB967871A (en) | Anorexigenic compositions comprising ª-phenylisopropylamine derivatives | |
GB976096A (en) | Pharmaceutical compositions | |
Javett et al. | Acrodynia treated with D-penicillamine | |
RU2030179C1 (en) | Antimicrobial and antifungous agent | |
Hayes et al. | Fulminating meningococcemia (Waterhouse-Friderichsen syndrome): an unusual case with recovery following treatment with penicillin | |
JP2002265354A (en) | Anti-helicobacter pylori agent composition | |
SU449724A1 (en) | Mukaltin Expectorant | |
SU552085A1 (en) | Medication for the treatment of blood coagulation disorders in thrombocytopenic conditions of various origins and for the stimulation of erythrophosphatid hemopoiesis | |
Davidson et al. | The treatment of congenital syphilis with stovarsol |